Document

We consent to the reference to our firm under the caption “Experts” in the Registration Statement (Form S-3) and related Prospectus of Ginkgo Bioworks Holdings, Inc. for the registration of 18,857,026 shares of its Class A common stock and to the incorporation by reference therein of our reports dated February 29, 2024, with respect to the consolidated financial statements of Ginkgo Bioworks Holdings, Inc., and the effectiveness of internal control over financial reporting of Ginkgo Bioworks Holdings, Inc., included in its Annual Report (Form 10-K) for the year ended December 31, 2023, filed with the Securities and Exchange Commission.